Only 57% of people with diabetes have well-controlled blood glucose levels — defined by the American Diabetes Association as a three-month target blood glucose level (hemoglobin A1c) of less than 7% or defined by the American Association of Clinical Endocrinologists as less than 6.5%. For some people with diabetes, help may already be here in the form of the daily or weekly dosed glucagon-like-peptide-1 receptor agonists exenatide (Byetta, Bydureon), liraglutide (Victoza), dulaglutide (Trulicity), albiglutide (Tanzeum) and the amylin analog pramlintide acetate (Symlin). Many nurses and dietitians who work with patients with diabetes will have the responsibility of educating and monitoring patients who are using these important new treatments.
The goal of this program is to enhance nurses’ and dietitians’ ability to care for patients taking new injectable classifications of medications for diabetes. After studying the information presented here, you will be able to:
- Describe the roles of amylin and the human incretin hormone glucagon-like-peptide-1 in regulating blood glucose levels
- Explain three benefits of GLP-1 receptor agonists and amylin analog injection therapy
- Discuss three nursing interventions to help patients adjust to and properly use GLP-1 receptor agonists or amylin analog therapy
This course is intended for multiple professions, including dietitians, health educators, and nurses.
Dietitians: Take this version of the course to ensure you receive appropriate credit.
For the version accredited or approved for another profession, go to your specific profession at www.continuingeducation.com
. If you have a CE Direct login ID and password (generally provided by your employer), please log in as you normally would at lms.nurse.com
and search for this topic title.
OnCourse Learning is a Continuing Professional Education (CPE) Accredited Provider (#GD001) with the Commission on Dietetic Registration (CDR). This course is a level 2 course with suggested CDR learning codes of 3000, 3070, 4000, 4040, 5000, 5190, 5290, 5370, 5390 and performance indicators of 8.1.5, 8.3.6, 8.3.7, 10.2.4.
OnCourse Learning is also accredited by the Florida Council of Dietetics and Nutrition (provider # FBN 50-1489).
This program has been approved for fulfilling the continuing education requirements of the Certifying Board for Dietary Managers (CBDM). Granting prior approval does not constitute endorsement of the program content or its program sponsor.
Course Originally Released on:
Date of Most Recent Review:
Course Termination/Update Date:
Unless stated above, the planners and authors of this course have declared no relevant conflicts of interest that relate to this educational activity. OnCourse Learning guarantees this educational activity is free from bias.
Please see CE Course Instructions to learn how to earn CE credit for this module.
For Florida professionals:
This course completion will be electronically reported to CE Broker as required per Florida Statute 456.025(7). Click here to view your CE Broker transcript and check the status of your CE requirements with a FREE 7-day CE Broker trial subscription. It may take up to 24 hours for the course to appear on your CE Broker transcript.
It is now required that all CE is completed and reported to CE Broker before you renew your license. When you complete continuing education with us, OnCourse Learning will report your hours for you.
Read more about the new license renewal process at AreYouRenewalReady.com and claim your free Basic Account in CE Broker to see what has already been reported for you.
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid FL license number. This information is required for correct reporting of your course completions to CE Broker.